Syros Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SYRS
CUSIP
87184Q206
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 87184Q206 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Avidity Partners Management LP 13G/A
7.6%
Checked 5% or less
2/14/2025
Event 12/31/2024
Samsara BioCapital, L.P. 13D/A
2.6% 3/27/2025
Event 11/18/2024
Adage Capital Partners GP, L.L.C. 13G/A
2.0% 2/12/2025
Event 12/31/2024
Point72 Asset Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q1 7 483 k $12.4k
2024 Q4 48 5.23 M $1.20M
2024 Q3 70 19.0 M $40.8M
2024 Q2 71 20.4 M $105M
2024 Q1 78 20.9 M $112M
2023 Q4 60 19.2 M $147M
2023 Q3 50 12.1 M $47.9M
2023 Q2 55 10.6 M $33.5M
2023 Q1 59 10.3 M $27.5M
2022 Q4 57 10.6 M $37.9M
2022 Q3 52 8.45 M $54.4M